Cutaneous T-Cell Lymphoma: Two Faces of the Same Coin

被引:5
作者
Wozniak, Magdalena B. [1 ]
Piris, Miguel A. [1 ]
机构
[1] Spanish Natl Canc Res Ctr, Mol Pathol Program, Madrid, Spain
关键词
NF-KAPPA-B; EXPRESSION; APOPTOSIS; RECEPTOR; TRAF1; CD30;
D O I
10.1038/jid.2009.373
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Primary cutaneous anaplastic large-cell lymphoma (C-ALCL) and cutaneous peripheral T-cell lymphoma not otherwise specified (C-PTL-NOS) are cutaneous T-cell lymphomas with distinct clinical behaviors. Whereas C-ALCL has a favorable prognosis with frequent spontaneous disease regression, C-PTL-NOS runs a more aggressive course. The molecular pathogenesis of these cutaneous T-cell lymphoma types has not yet been studied in detail. In this issue, van Kester et al. report new imbalances that could contribute to our understanding of the differences between these two lymphoma types.
引用
收藏
页码:348 / 351
页数:4
相关论文
共 11 条
[1]   Differential expression of TRAH aids in the distinction of cutaneous CD30-positive lymphoproliferations [J].
Assaf, Chalid ;
Hirsch, Burkhard ;
Wagner, Florian ;
Lucka, Lothar ;
Gruenbaum, Maria ;
Gellrich, Sylke ;
Lukowsky, Ansgar ;
Sterry, Wolfram ;
Stein, Harald ;
Duerkop, Horst .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (08) :1898-1904
[2]   Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling [J].
Bonzheim, I ;
Geissinger, E ;
Roth, S ;
Zettl, A ;
Marx, A ;
Rosenwald, A ;
Müller-Hermelink, HK ;
Rüdiger, T .
BLOOD, 2004, 104 (10) :3358-3360
[3]   Induction of nuclear factor kappa B by the CD30 receptor is mediated by TRAF1 and TRAF2 [J].
Duckett, CS ;
Gedrich, RW ;
Gilfillan, MC ;
Thompson, CB .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (03) :1535-1542
[4]   TRAF1 is involved in the classical NF-κB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells [J].
Guo, Feng ;
Sun, Aining ;
Wang, Wenjuan ;
He, Jun ;
Hou, Jianquan ;
Zhou, Peng ;
Chen, Zixing .
MOLECULAR IMMUNOLOGY, 2009, 46 (13) :2441-2448
[5]   Chemokines:: Agents for the immunotherapy of cancer? [J].
Homey, B ;
Müller, A ;
Zlotnik, A .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (03) :175-184
[6]   Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: A possible mechanism for disease progression [J].
Levi, E ;
Wang, ZX ;
Petrogiannis-Haliotis, T ;
Pfeifer, WM ;
Kempf, W ;
Drews, R ;
Kadin, ME .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (06) :1034-1040
[7]   NF-κB:: tumor promoter or suppressor? [J].
Perkins, ND .
TRENDS IN CELL BIOLOGY, 2004, 14 (02) :64-69
[8]   Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis [J].
Sneller, MC ;
Wang, J ;
Dale, JK ;
Strober, W ;
Middelton, LA ;
Choi, YN ;
Fleisher, TA ;
Lim, MS ;
Jaffe, ES ;
Puck, JM ;
Lenardo, MJ ;
Straus, SE .
BLOOD, 1997, 89 (04) :1341-1348
[9]   Cutaneous Anaplastic Large Cell Lymphoma and Peripheral T-Cell Lymphoma NOS Show Distinct Chromosomal Alterations and Differential Expression of Chemokine Receptors and Apoptosis Regulators [J].
van Kester, Marloes S. ;
Tensen, Cornelis P. ;
Vermeer, Maarten H. ;
Dijkman, Remco ;
Mulder, Aat A. ;
Szuhai, Karoly ;
Willemze, Rein ;
van Doorn, Remco .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (02) :563-575
[10]   WHO-EORTC classification for cutaneous lymphomas [J].
Willemze, R ;
Jaffe, ES ;
Burg, G ;
Cerroni, L ;
Berti, E ;
Swerdlow, SH ;
Ralfkiaer, E ;
Chimenti, S ;
Diaz-Perez, JL ;
Duncan, LM ;
Grange, F ;
Harris, NL ;
Kempf, W ;
Kerl, H ;
Kurrer, M ;
Knobler, R ;
Pimpinelli, N ;
Sander, C ;
Santucci, M ;
Sterry, W ;
Vermeer, MH ;
Wechsler, J ;
Whittaker, S ;
Meijer, CJLM .
BLOOD, 2005, 105 (10) :3768-3785